Want to see NZ:SCL full AI Analyst Report?
Top Page
Scales Corp. Ltd.
(SCL)
Select Model
Select Model
Rating:69Neutral
Price Target:
$7.50
Action:N/A
Date:10/05/26
The score is primarily supported by improved 2025 financial performance and an attractive valuation (P/E ~11.5 and ~4.1% yield). Offsetting this are balance sheet and cash-flow quality risks (higher leverage and weak 2025 cash conversion) plus softer near-term technical momentum (below 20/50-day averages with negative MACD).
Positive Factors
Broad-based 2026 earnings growth
Broad-based growth across all three operating divisions reduces reliance on a single business line and indicates stronger underlying demand, volume and portfolio contributions. The upgraded full-year guidance also supports confidence that improved earnings can extend beyond one isolated reporting period.
Negative Factors
Materially higher leverage
The substantial increase in leverage reduces financial flexibility compared with Scales’ more conservatively financed 2021–2024 period. Higher debt can constrain future capital allocation and make the business more sensitive to weaker operating performance, especially while expanding through acquisitions.
Read all positive and negative factors
Positive Factors
Negative Factors
Broad-based 2026 earnings growth
Broad-based growth across all three operating divisions reduces reliance on a single business line and indicates stronger underlying demand, volume and portfolio contributions. The upgraded full-year guidance also supports confidence that improved earnings can extend beyond one isolated reporting period.
Read all positive factors
Scales Corp. Ltd. (SCL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$974.75M
Dividend Yield4.09%
Average Volume (3M)144.26K
Price to Earnings (P/E)11.2
Beta (1Y)0.93
Revenue Growth100.12%
EPS Growth60.22%
CountryNZ
Employees867
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.58
Shares Outstanding146,579,150
10 Day Avg. Volume117,727
30 Day Avg. Volume144,263
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.92
Price to Sales (P/S)0.93
P/FCF Ratio11.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.41
Revenue Forecast (FY)$1.44B
Scales Corp. Ltd. Business Overview & Revenue Model
Company Description
Scales Corporation Limited engages in manufacturing and trading of food ingredients in New Zealand, Asia, Europe, North America, and internationally. It operates through Global Proteins, Horticulture, Logistics, and Other segments. The company pro...
How the Company Makes Money
SCL makes money primarily through earnings generated by its operating subsidiaries, which are consolidated into group revenue and profit. A core revenue stream comes from its horticulture operations (commonly associated with produce such as apples...
Scales Corp. Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
70
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.30B | 911.63M | 587.06M | 565.36M | 619.17M | 501.83M |
| Gross Profit | 202.47M | 179.35M | 434.56M | 120.69M | 445.06M | 367.79M |
| EBITDA | 138.58M | 125.48M | 87.78M | 52.59M | 64.94M | 69.66M |
| Net Income | 82.45M | 100.99M | 30.73M | 5.24M | 19.41M | 26.93M |
Balance Sheet | ||||||
| Total Assets | 1.03B | 899.85M | 608.92M | 581.66M | 580.46M | 584.77M |
| Cash, Cash Equivalents and Short-Term Investments | 51.09M | 64.67M | 53.75M | 77.64M | 68.14M | 120.40M |
| Total Debt | 274.35M | 262.37M | 107.64M | 121.28M | 96.09M | 117.97M |
| Total Liabilities | 565.90M | 443.34M | 227.41M | 196.71M | 188.64M | 194.46M |
| Stockholders Equity | 455.47M | 443.64M | 367.59M | 373.35M | 384.44M | 384.39M |
Cash Flow | ||||||
| Free Cash Flow | 107.05M | 74.86M | 42.62M | 47.57M | 29.28M | 23.31M |
| Operating Cash Flow | 124.97M | 95.77M | 97.56M | 64.70M | 44.87M | 39.84M |
| Investing Cash Flow | -34.70M | -81.33M | -49.10M | -29.17M | 38.72M | 7.78M |
| Financing Cash Flow | -87.61M | -4.39M | -72.60M | -23.29M | -52.54M | -61.13M |
Scales Corp. Ltd. Technical Analysis
Negative
―
Price Trends
6.82
Negative
6.52
Negative
6.18
Positive
Market Momentum
-0.06
Positive
38.60
Neutral
16.16
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:SCL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 6.76, equal to the 50-day MA of 6.82, and equal to the 200-day MA of 6.18, indicating a neutral trend. The MACD of -0.06 indicates Positive momentum. The RSI at 38.60 is Neutral, neither overbought nor oversold. The STOCH value of 16.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:SCL.
Scales Corp. Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $217.66M | 5.39 | ― | 12.44% | 0.48% | 38.02% | |
69 Neutral | $974.75M | 11.21 | ― | 4.09% | 100.12% | 60.22% | |
69 Neutral | $5.99B | 25.89 | 17.63% | 7.73% | 3.84% | 6.53% | |
67 Neutral | $426.77M | 10.56 | ― | 6.13% | 4.14% | -19.51% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | $268.37M | 22.18 | ― | 6.67% | -17.18% | 196.29% |
* General Sector Average
NZ:SCL
Scales Corp. Ltd.
6.50
0.94
16.89%
NZ:ATM
a2 Milk Company
8.15
-1.30
-13.79%
NZ:SEK
Seeka Limited
5.22
1.29
32.89%
NZ:DGL
Delegat Group Limited
4.18
0.17
4.24%
NZ:FCG
Fonterra Co-operative Group Limited
4.78
-0.26
-5.22%
NZ:TGG
T&G Global Limited
2.22
0.17
8.29%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.